Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Functional assay [1]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16-0157-82 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- IL-15 Monoclonal Antibody (ct2nu), Functional Grade, eBioscience™
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Description
- Description: The ct2nu monoclonal antibody reacts with human IL-15 and neutralizes its bioactivity. IL-15, or IL-T, is a 14 kDa proinflammatory cytokine and member of the IL-2 family. It plays a role in the development and maturation of macrophages and dendritic cells, and is essential to the proliferation and survival of NK cells and CD8^+ T cells. IL-15 is expressed by antigen-presenting cells, epithelial cells, and stromal cells. IL-15 activates the Jak/STAT pathway through its heterotrimeric receptor. Two subunits of this receptor, the beta and gamma chains, are shared with the rest of the family, while the alpha subunit is unique to IL-15. In mice, the alpha chain is required to chaperone IL-15 from the ER to secretion. This chaperoning is not necessary in humans, and free IL-15 is detectable in human biological samples. However, the receptor-cytokine complex has been indentified in humans and demonstrates agonistic activity several-fold higher than IL-15 alone. Applications Reported: The monoclonal antibody ct2nu reacts with and inhibits the bioactivity of human IL-15. Applications Tested: The ND50 of this antibody, as measured by inhibition of proliferation in CTLL-2 cells, is 1-10 ng/mL in the presence of 0.5 ng/mL recombinant human IL-15. Neutralization dose will vary based on cell type, cytokine concentration, and assay method. This antibody should be carefully titrated for optimal performance in the assay of interest. Storage and handling: Use in a sterile environment. Filtration: 0.2 µm post-manufacturing filtered. Purity: Greater than 90%, as determined by SDS-PAGE. Endotoxin Level: Less than 0.001 ng/µg antibody, as determined by LAL assay. Aggregation: Less than 10%, as determined by HPLC.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- ct2nu
- Vial size
- 100 µg
- Concentration
- 1 mg/mL
- Storage
- 4°C
Submitted references Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens.
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens.
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.
IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions.
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Interleukin 15: biology and relevance to human disease.
Mysore V, Cullere X, Settles ML, Ji X, Kattan MW, Desjardins M, Durbin-Johnson B, Gilboa T, Baden LR, Walt DR, Lichtman AH, Jehi L, Mayadas TN
Med (New York, N.Y.) 2021 Sep 10;2(9):1050-1071.e7
Med (New York, N.Y.) 2021 Sep 10;2(9):1050-1071.e7
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens.
Mysore V, Cullere X, Settles ML, Ji X, Kattan MW, Desjardins M, Durbin-Johnson B, Gilboa T, Baden LR, Walt DR, Lichtman A, Jehi L, Mayadas TN
bioRxiv : the preprint server for biology 2021 May 4;
bioRxiv : the preprint server for biology 2021 May 4;
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.
Witkowski M, Tizian C, Ferreira-Gomes M, Niemeyer D, Jones TC, Heinrich F, Frischbutter S, Angermair S, Hohnstein T, Mattiola I, Nawrath P, McEwen S, Zocche S, Viviano E, Heinz GA, Maurer M, Kölsch U, Chua RL, Aschman T, Meisel C, Radke J, Sawitzki B, Roehmel J, Allers K, Moos V, Schneider T, Hanitsch L, Mall MA, Conrad C, Radbruch H, Duerr CU, Trapani JA, Marcenaro E, Kallinich T, Corman VM, Kurth F, Sander LE, Drosten C, Treskatsch S, Durek P, Kruglov A, Radbruch A, Mashreghi MF, Diefenbach A
Nature 2021 Dec;600(7888):295-301
Nature 2021 Dec;600(7888):295-301
IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions.
Sattler A, Dang-Heine C, Reinke P, Babel N
European journal of immunology 2015 Aug;45(8):2286-98
European journal of immunology 2015 Aug;45(8):2286-98
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, Corcuff E, Mortier E, Jacques Y, Spits H, Di Santo JP
The Journal of experimental medicine 2009 Jan 16;206(1):25-34
The Journal of experimental medicine 2009 Jan 16;206(1):25-34
Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans.
Rowley J, Monie A, Hung CF, Wu TC
Journal of immunology (Baltimore, Md. : 1950) 2008 Dec 15;181(12):8237-47
Journal of immunology (Baltimore, Md. : 1950) 2008 Dec 15;181(12):8237-47
Interleukin 15: biology and relevance to human disease.
Fehniger TA, Caligiuri MA
Blood 2001 Jan 1;97(1):14-32
Blood 2001 Jan 1;97(1):14-32
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Neutralization of Human IL-15 Recombinant Protein activity, as measured by CTLL-2 proliferation.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Neutralization of Human IL-15 Recombinant Protein activity, as measured by CTLL-2 proliferation.